Apremilast as therapeutic option in a HIV positive patient with severe psoriasis
Author:
Affiliation:
1. Department of Specialized, Clinical and Experimental Medicine, Division of Dermatology; University of Bologna; Bologna Italy
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dth.12719/fullpdf
Reference6 articles.
1. Secukinumab in the treatment of palmoplantar, nail, scalp and pustular psoriasis;Armstrong;Journal of Clinical and Aesthetic Dermatology,2016
2. Biologic therapies in HIV-infected patients with psoriasis: An Italian experience;Bardazzi;Acta dermato-venereologica,2017
3. Ustekinumab for the treatment of HIV psoriasis;Paparizos;The Journal of Dermatology,2012
4. Apremilast for a psoriatis patient with HIV and hepatitis C;Reddy;Journal of the European Academy of Dermatology and Venereology,2017
5. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis;Schafer;Biochemical Pharmacology,2012
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature;Dermatology Practical & Conceptual;2022-10-31
2. Successful treatment with secukinumab in an HIV ‐positive psoriatic patient after failure of apremilast;Dermatologic Therapy;2022-06-07
3. The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios;Psoriasis: Targets and Therapy;2021-08
4. The unforeseen during biotechnological therapy for moderate‐to‐severe psoriasis: How to manage pregnancy and breastfeeding, infections from Mycobacterium tuberculosis , hepatitis B virus, hepatitis C virus, and HIV , surgery, vaccinations, diagnosis of malignancy, and dose tapering;Dermatologic Therapy;2020-04-30
5. Apremilast in people living with HIV with psoriasis vulgaris: A case report;Indian Journal of Dermatology;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3